Essential
tremor, a nerve
disorder, is characterized by involuntary tremors or shaking in different parts
of the body. The most common affected areas are head, arms, hands, larynx, chin
and tongue.
This disease
creates difficulties in daily activities such as eating, writing and dressing.
Essential tremor is caused by genetic defects which results in abnormal brain
activity. The disease is also linked with other movement disorders including
Parkinson’s disease, migraine and headache. Essential tremor can be treated by
medications, and deep brain stimulation devices.
Request to Get Free Sample Pages at: https://www.pharmaproff.com/request-sample/1099
Neurocrine
Biosciences Inc. is in the process of developing NBI-640756, an oral small
molecule, for the treatment of essential tremor. Cavion Inc. is other key
player involved in the development of drugs for the management of this medical
condition.
Make
Enquiry Before Buying the Report: https://www.pharmaproff.com/enquiry/1099
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.
No comments:
Post a Comment